Sector : Pharmaceuticals
BSE
350.80 -2.6%
NSE
350.70 -2.57 %
Jan 14, 11:42
Fitch assigns 'BB' rating to Glenmark's proposed US dollar-denominated senior unsecured notes
Dec 23, 14:21
Mankind Pharma inks licensing pact with Glenmark to co-market diabetes drug
Dec 20, 11:35
Glenmark gets approval from Australian regulator to commercialise Ryaltris
Dec 17, 21:23
Vildagliptin's patent expiry to make way for new SGLT2-based drugs for type-2 diabetes treatment
Jan 20, 16:00
Price
BSE
350.80 -2.6%
NSE
350.70 -2.57%
Share Target
Target(Rs)
Tip Period
Stop Loss
Your permanent Nickname can be distinct from your username and no one need know the link between the two.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
